ALAMEDA, Calif., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (Nasdaq: VANI) ("Vivani" or the "Company"), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting drug implants utilizing its proprietary NanoPortal™ technology, today announced its planned participation in two upcoming investor conferences: Lake Street Capital Markets 10th Annual Best Ideas Growth ConferenceSeptember 10, 2026Metropolitan ClubNew York, New YorkH.C. Wainwright 28th Annual Global
Novo Nordisk is leaning into convenience as it tries to regain its lead in the GLP-1 weight-loss space.
This is the newest page. Registered accounts read further back.